Mirum Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIRM and other ETFs, options, and stocks.

About MIRM

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. 

CEO
Christopher Peetz
CEOChristopher Peetz
Employees
372
Employees372
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
2018
Founded2018
Employees
372
Employees372

MIRM Key Statistics

Market cap
6.31B
Market cap6.31B
Price-Earnings ratio
-6.67
Price-Earnings ratio-6.67
Dividend yield
Dividend yield
Average volume
602.07K
Average volume602.07K
High today
$102.00
High today$102.00
Low today
$97.00
Low today$97.00
Open price
$100.73
Open price$100.73
Volume
351.42K
Volume351.42K
52 Week high
$130.00
52 Week high$130.00
52 Week low
$63.23
52 Week low$63.23

Stock Snapshot

Mirum Pharmaceuticals(MIRM) stock is priced at $97.07, giving the company a market capitalization of 6.31B. It carries a P/E multiple of -6.67.

As of 2026-08-21, Mirum Pharmaceuticals(MIRM) stock has fluctuated between $97.00 and $102.00. The current price stands at $97.07, placing the stock +0.1% above today's low and -4.8% off the high.

Mirum Pharmaceuticals(MIRM) shares are trading with a volume of 351.42K, against a daily average of 602.07K.

In the last year, Mirum Pharmaceuticals(MIRM) shares hit a 52-week high of $130.00 and a 52-week low of $63.23.

In the last year, Mirum Pharmaceuticals(MIRM) shares hit a 52-week high of $130.00 and a 52-week low of $63.23.

MIRM News

Simply Wall St 5d
Will Mirum Pharmaceuticals' Widening Net Losses Test Its Growth-Focused Investment Narrative?

Mirum Pharmaceuticals, Inc. reported past earnings for the second quarter and first half of 2026, disclosing a net loss of US$67.23 million for the quarter and...

Will Mirum Pharmaceuticals' Widening Net Losses Test Its Growth-Focused Investment Narrative?

Analyst ratings

100%

of 14 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own MIRM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.